**Question:** NANA antibody is seen in -

A. Anti-A
B. Anti-B
C. Anti-D
D. Anti-E

**Correct Answer:** C. Anti-D

**Core Concept:**
NANA antibody is a term used to describe a specific type of immunoglobulin called anti-D, which is produced in response to the Rh incompatibility between a mother's blood type (Rh factor) and that of her fetus. The Rh factor is a protein found on the surface of red blood cells, and it can be either positive or negative. In the context of pregnancy, if the mother's blood type is Rh-negative (Rh-) and the baby is Rh-positive (Rh+), the mother's immune system will recognize the baby's Rh+ cells as foreign and produce anti-D antibodies.

**Why the Correct Answer is Right:**
Anti-D is the correct answer because it is the type of NANA antibody specifically produced in response to Rh incompatibility in pregnant women. When a Rh-negative mother is exposed to Rh-positive fetal cells during pregnancy or childbirth, her immune system produces anti-D antibodies to combat the foreign cells. These antibodies can cross the placenta and enter the fetal circulation, leading to a condition called Rh disease. In severe cases, this can result in anemia, jaundice, and even death if left untreated.

**Why Each Wrong Option is Incorrect:**

A. Anti-A and Anti-B (options A and B) are incorrect because they represent other types of NANA antibodies produced due to Rh incompatibility involving A and B antigens, respectively. These antibodies are not specific to Rh disease and may not cross the placenta as effectively as Anti-D.

D. Anti-E (option D) is incorrect because it represents another type of NANA antibody produced due to Rh incompatibility involving E antigen. Similar to Anti-A and Anti-B, Anti-E is not specific to Rh disease and does not cross the placenta as efficiently as Anti-D.

**Clinical Pearls:**
1. Rh disease is a significant issue in obstetrics, as it can have severe consequences for the fetus.
2. NANA antibodies (anti-D, anti-A, anti-B, anti-E) are produced when a mother's immune system recognizes Rh-positive fetal cells as foreign.
3. Knowledge of these antibodies and their implications is essential for healthcare professionals involved in obstetrics and neonatology, ensuring prompt diagnosis and intervention for affected pregnancies.